Get the Stockscreener App
11.00
3.19%
0.34
After Hours:
11.60
0.60
+5.45%
Champions Oncology Inc stock is traded at $11.00, with a volume of 36,420.
It is up +3.19% in the last 24 hours and up +4.76% over the past month.
Champions Oncology Inc is a USA based company which is engaged in the development and sale of state of the art technology solutions and products to personalize the development and use of oncology drugs. The company operates through one segment namely Personalized Oncology Solutions (POS) and Translational Oncology Solutions (TOS). Its POS business assists physicians in developing personalized treatment options for their cancer patients through tumor-specific data obtained from drug panels and related personalized oncology services. The TOS business assists pharmaceutical and biotechnology companies with their drug development process and offers studies or license tumors for use in studies. The company's revenue is majorly derived from research services.
See More
Previous Close:
$10.66
Open:
$10.65
24h Volume:
36,420
Relative Volume:
0.73
Market Cap:
$156.10M
Revenue:
$49.98M
Net Income/Loss:
$-9.64M
P/E Ratio:
-15.49
EPS:
-0.71
Net Cash Flow:
$-4.86M
1W Performance:
+0.09%
1M Performance:
+4.76%
6M Performance:
+144.44%
1Y Performance:
+81.16%
1-Day Range:
$10.20
$11.75
1-Week Range:
$9.41
$11.75
52-Week Range:
$3.6001
$11.99
Champions Oncology Inc Stock (CSBR) Company Profile
Name
Champions Oncology Inc
Sector
Industry
Phone
410-369-0365
Address
855 N. WOLFE STREET, BALTIMORE, NJ
Compare CSBR with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
CSBR
Champions Oncology Inc
|
11.00 | 156.10M | 49.98M | -9.64M | -4.86M | -0.71 |
|
VRTX
Vertex Pharmaceuticals Inc
|
469.23 | 122.13B | 10.63B | -479.80M | -1.35B | -1.99 |
|
REGN
Regeneron Pharmaceuticals Inc
|
710.00 | 78.30B | 14.20B | 4.41B | 3.54B | 38.28 |
|
ARGX
Argen X Se Adr
|
646.64 | 39.73B | 1.86B | -40.29M | -1.28B | -0.85 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
276.19 | 35.50B | 2.09B | -332.26M | 16.06M | -2.62 |
|
BNTX
Biontech Se Adr
|
117.61 | 28.47B | 3.30B | -501.07M | 1.03B | -2.1146 |
Champions Oncology Inc Stock (CSBR) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Sep-12-24 | Upgrade | Craig Hallum | Hold → Buy |
| Nov-18-19 | Initiated | The Benchmark Company | Speculative Buy |
Champions Oncology Inc Stock (CSBR) Latest News
Champions Oncology Reports Quarterly Revenue of $12.9 Million - ACCESS Newswire
Why IMAC Holdings Shares Are Trading Higher By Over 108%; Here Are 20 Stocks Moving Premarket - Benzinga
Champions Oncology Reports Quarterly Revenue of $13.5 Million Adjusted EBITDA of $1.1 Million - ACCESS Newswire
Champions Oncology to Announce Third Quarter Financial Results on Tuesday, March 12, 2024 - ACCESS Newswire
CSBR stock hits 52-week high at $10.91 amid robust growth - MSN
(CSBR) Trading Advice - Stock Traders Daily
12 Health Care Stocks Moving In Friday's Pre-Market Session - Benzinga
Addressing Climate Change by Changing Our Food Systems - NTB Kommunikasjon
Pre-market Movers: SAGE, ITCI, GCTK, MRNA... - RTTNews
A Look At The Intrinsic Value Of Champions Oncology, Inc. (NASDAQ:CSBR) - Yahoo Finance
American Battery Technology appoints new interim CFO - Investing.com
AML Incubator Launches Compliance Solution for European MSBs and VASPs Facing MiCA Regulatory Challenges - Via Ritzau
Champions Oncology integrates Cytek Aurora flow cytometers - Yahoo Finance
IXOPAY & Riskified Announce Partnership to Boost Fraud Prevention and Enhance Enterprise Payment Orchestration - Via Ritzau
Champions Oncology bolsters bioanalytical services By Investing.com - Investing.com Canada
Champions Oncology bolsters bioanalytical services - Investing.com India
Champions Oncology Enhances Clinical Bioanalytical Services Portfolio with New Technology and Additional Leadership - AccessWire
Champions Oncology Boosts Bioanalytical Services with Cytek Aurora Tech and Key Executive Hire - StockTitan
Champions Oncology, Inc.'s (NASDAQ:CSBR) market cap up US$26m last week, benefiting both private equity firms who own 30% as well as insiders - Simply Wall St
Linacre Investments Limited Delivers Record-Breaking Returns for 2024 - Via Ritzau
Biotech Startups Get a Boost: ZAGENO and Hatch.Bio Labs Partner to Streamline Lab Operations - Via Ritzau
Patient Derived Xenograft Model Market Future Business - openPR
CSBR stock hits 52-week high at $9.94 amid growth By Investing.com - Investing.com Australia
CSBR stock hits 52-week high at $9.94 amid growth - Investing.com
Learn to Evaluate (CSBR) using the Charts - News
Champions Oncology Reports Quarterly Revenue of $6.7 Million - AccessWire
CSBR stock touches 52-week high at $8.92 amid robust growth - Investing.com Nigeria
CSBR stock touches 52-week high at $8.92 amid robust growth By Investing.com - Investing.com South Africa
Champions Oncology: Right Point To Own In The Cycle Thanks To Operating Efficiencies - Seeking Alpha
Beyond Work Unveils Next-Generation Memory-Augmented AI Agent (MATRIX) for Enterprise Document Intelligence - Via Ritzau
Private equity firms invested in Champions Oncology, Inc. (NASDAQ:CSBR) up 19% last week, insiders too were rewarded - Yahoo Finance
CSBR stock hits 52-week high at $7.15 amid robust growth - Investing.com Australia
Champions Oncology Second Quarter 2025 Earnings: EPS: US$0.054 (vs US$0.15 loss in 2Q 2024) - Simply Wall St
Champions Oncology, Inc. Reports Earnings Results for the Second Quarter and Six Months Ended October 31, 2024 - Marketscreener.com
Champions Oncology, Inc. (NASDAQ:CSBR) Q2 2025 Earnings Call Transcript - Insider Monkey
Champions Oncology Inc. (CSBR) reports earnings - Quartz
Pre-market Movers: PALI, KROS, AVGR, TRVI... - RTTNews
Earnings call transcript: Champions Oncology Q2 2024 beats forecasts, stock surges - Investing.com
Champions Oncology Posts Strong Quarterly Revenue Growth - TipRanks
Champions Oncology earnings beat by $0.08, revenue topped estimates - Investing.com Canada
Stocks to Watch : Adobe, Champions Oncology, DBV Technologies - Marketscreener.com
Stocks to Watch: Adobe, Champions Oncology, DBV Technologies - MarketWatch
Champions Oncology Shares Rise on Higher 2Q Profit, Revenue - MarketWatch
Champions Oncology Q2 Earnings Surge: Revenue Soars 17% as Operational Efficiency Drives Profitability - StockTitan
Adobe, Macy's, Nordson, and more set to report earnings Wednesday By Investing.com - Investing.com Nigeria
3 US Dividend Stocks To Consider With Up To 4.6% Yield - Simply Wall St
Champions Oncology Inc Stock (CSBR) Financials Data
Revenue
Net Income
Cash Flow
EPS
1.09%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):